{"id":15850,"date":"2025-02-06T10:49:47","date_gmt":"2025-02-06T10:49:47","guid":{"rendered":"https:\/\/www.mediconanet.pt\/?p=15850"},"modified":"2025-11-07T18:19:27","modified_gmt":"2025-11-07T18:19:27","slug":"migraine-in-portugal-impact-and-updated-figures","status":"publish","type":"post","link":"https:\/\/www.mediconanet.pt\/en\/enxaqueca-em-portugal-impacto-e-numeros-atualizados\/","title":{"rendered":"Migraine in Portugal: Impact and Updated Figures"},"content":{"rendered":"

Migraine in Portugal is a chronic neurological condition that affects a significant portion of the population, with estimates indicating that around 1.5 million Portuguese suffer from the condition.<\/p>\n\n\n\n

How many people suffer from migraines in Portugal?<\/strong><\/h2>\n\n\n\n

In Portugal, it is estimated that one in five women and one in ten men are affected by migraine. This condition manifests itself through intense headaches, often accompanied by nausea, vomiting and hypersensitivity to light and sound.<\/p>\n\n\n\n

The impact of migraine on people's quality of life is significant. Studies indicate that 791% of Portuguese patients feel limited in carrying out daily tasks due to migraine. In addition, 811,000,000 people say that migraine affects their social lives, with 391,000,000 saying that it limits hobbies and activities. <\/p>\n\n\n\n

The Cost of Migraine: Economic Impact<\/strong><\/h2>\n\n\n\n

Migraine is one of the main causes of absenteeism from work in Portugal. It is estimated that the loss of productivity associated with migraine has a significant economic cost for the country, although the exact figures may vary depending on the studies and methodologies used. <\/p>\n\n\n\n

\"Woman<\/figure>\n\n\n\n

Access to Health Care and Treatment<\/strong> for Migraine<\/strong><\/h2>\n\n\n\n

Despite the high prevalence of migraine, many sufferers face challenges in accessing adequate healthcare. A survey carried out by MiGRA Portugal<\/a> revealed that 60% of patients being treated for migraine express dissatisfaction with their treatment, and between 55% and 70% remain unaware of innovative treatment options. <\/p>\n\n\n\n

In addition, around 401,000,000 patients do not receive regular medical care, and 701,000,000 of those who do have to go to the private sector. <\/p>\n\n\n\n

The Main Challenges of Migraine and How to Overcome Them<\/strong><\/h2>\n\n\n\n

Migraine is often undervalued by society and is often considered just a headache. This stigma contributes to a lack of understanding and support for sufferers, making early diagnosis and access to effective treatments difficult. <\/p>\n\n\n\n

It is essential to raise awareness of migraine by educating the population and health professionals, so that the condition is recognised as a legitimate and treatable neurological disease.<\/p>\n\n\n\n

The Road to a Better Quality of Life<\/strong><\/h2>\n\n\n\n

Migraine is a prevalent condition in Portugal, with a significant impact on the quality of life of those affected and on the national economy. It is imperative that strategies are adopted to improve diagnosis, treatment and support for sufferers, combating the associated stigma and promoting a more effective and comprehensive approach to this pathology. If you suffer from migraine and are looking for specialised support, the Doctor on the Net<\/strong> has a dedicated treatment consultation<\/a> of this condition, helping to improve their quality of life with personalised solutions.<\/p>","protected":false},"excerpt":{"rendered":"

A enxaqueca em Portugal \u00e9 uma condi\u00e7\u00e3o neurol\u00f3gica cr\u00f3nica que afeta uma parcela significativa da popula\u00e7\u00e3o, com estimativas indicando que cerca de 1,5 milh\u00f5es de portugueses sofrem desta patologia. Quantas Pessoas Sofrem de Enxaqueca em Portugal? Estima-se que, em Portugal, uma em cada cinco mulheres e um em cada dez homens sejam afetados pela enxaqueca. […]<\/p>\n","protected":false},"author":1393,"featured_media":15854,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[61],"tags":[120],"class_list":["post-15850","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicina-geral","tag-enxaqueca"],"jetpack_featured_media_url":"https:\/\/www.mediconanet.pt\/wp-content\/uploads\/2025\/02\/medico-na-net-enxaqueca-em-portugal.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/posts\/15850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/users\/1393"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/comments?post=15850"}],"version-history":[{"count":0,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/posts\/15850\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/media\/15854"}],"wp:attachment":[{"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/media?parent=15850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/categories?post=15850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mediconanet.pt\/en\/wp-json\/wp\/v2\/tags?post=15850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}